| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |